Hybrid Compound Design to Overcome the Gatekeeper T338M Mutation in cSrc

Getlik, Matthäus; Grütter, Christian; Simard, Jeffrey R.; Klüter, Sabine; Rabiller, Matthias; Rode, Haridas B.; Robubi, Armin; Rauh, Daniel

Lokale TagsFreigabegeschichteDetailsÜbersicht

Hybrid Compound Design to Overcome the Gatekeeper T338M Mutation in cSrc

Getlik, M., Grütter, C., Simard, J. R., Klüter, S., Rabiller, M., Rode, H. B., et al. (2009). Hybrid Compound Design to Overcome the Gatekeeper T338M Mutation in cSrc. Journal of Medicinal Chemistry, 52(13): 1, pp. 3915-3926. Retrieved from http://dx.doi.org/10.1021/jm9002928.

Item is Freigegeben

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:

Datensatz-Permalink: https://hdl.handle.net/11858/00-001M-0000-0014-037D-C Versions-Permalink: https://hdl.handle.net/11858/00-001M-0000-0014-037E-A

Genre: Zeitschriftenartikel

ausblenden:

Urheber:
Getlik, Matthäus¹, Autor
Grütter, Christian¹, Autor
Simard, Jeffrey R.¹, Autor
Klüter, Sabine¹, Autor
Rabiller, Matthias¹, Autor
Rode, Haridas B.¹, Autor
Robubi, Armin¹, Autor
Rauh, Daniel², Autor

Affiliations:
1Max Planck Institute of Molecular Physiology, Max Planck Society, ou_1753286
2Chemical Genomics Center of the MPS, Max Planck Institute of Molecular Physiology, Max Planck Society, ou_1753292